Treatment of type 1 diabetes mellitus with an autologous bone marrow adult stem cell implant in the pancreas;Tratamiento de la diabetes mellitus tipo 1 con implante pancreático de células madre adultas autólogas

Endocrinologia y Nutricion

Volumn 54, Issue 10, 2007, Pages 512-518

  Mesples, Alejandro Daniel ^a,b   Pretiñe, Basilio ^a   Bellomo, Raúl ^a  

^a TECNON   (Argentina)

^b NONE   (Argentina)

Author keywords

Adult stem cells; Peripheral arterial catheterization; Type 1 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTERY CATHETER; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; PANCREAS ISLET CELL;

EID: 37349107865     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(07)71497-3     Document Type: Article

References (29)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
2. Undlien DE, Thorsby E. HLA associations in type 1 diabetes: merging genetics and immunology. Trends Immunol. 2001;22:467-9.
3. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature. 2001;414:792-8.
4. Gruessner AC, Sutherland DE. Analysis of United States (US) and non-US pancreas transplants reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2001. En: Cecka JM, Terasaki PI, editores. Clinical transplants 2001. Los Angeles: UCLA Immunogenetics Center; 2002. p. 41-72.
5. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, et al. Insulin independence after islet transplantation into type I diabetic patient. Diabetes. 1990;39:515-8.
6. Shapiro J. Eighty years after insulin: parallels with modern islet transplantation. CMAJ. 2002;167:1398-400.
7. Nielsen JH, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes. 1986;35:1049-52.
8. Fabian MC, Lakey JR, Rajotte RV, Kneteman NM. The efficacy and toxicity of rapamycin in murine islet transplantation: in vitro and in vivo studies. Transplantation. 1993;56: 1137-42.
9. Redmon JB, Olson LK, Armstrong MB, Greene MJ, Robertson RP. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest. 1996;98:2786-93.
10. De la Tour D, Halvorsen T, Demeterco C, Tyrberg B, Itkin-Ansari P, Loy M, et al. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol. 2001;15:476-83.
11. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-94. [Erratum, Science. 2001;293:428.]
12. Assady S, Maor G, Amit M, Itskovitz-Elder J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes. 2001;50:1691-7.
13. Berna G, Leon-Quinto T, Ensenat-Waser R, Montanya E, Martin F, Soria B. Stem cells and diabetes. Biomed Pharmacother. 2001;55:206-12.
14. Edlund H. Factors controlling pancreatic cell differentiation and function. Diabetologia. 2001;44:1071-9.
15. Soria B. In-vitro differentiation of pancreatic beta-cells. Differentiation. 2001;68:205-19.
16. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin Yee I. The ISHAGE Guidelines for CD34+ cells determination by flow cytometry. J Hematother. 1996;5:213-26.
17. ADA. Expert Committee on the diagnosis and classification of Diabetes Mellitus. Report of the Experts. Diabetes Care. 1997;20:1183-97.
18. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease. Am J Cardiol. 2003;41:1721-4.
19. Assmus B, Schächinger V, Teupe C. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009-17.
20. Vicario JH, Campos C, Piva JR, Faccio F. Médula ósea autóloga vía seno coronario y angiogénesis en pacientes con angina crónica estable. Fase I. Rev Fed Arg Cardiol. 2004;33:357-63.
21. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 2002:416:545-8.
22. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, et al. Bone marrow -derived stem cells initiate pancreatic regeneration. Nature Biotechnology. 2003;21:763-70.
23. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003;111:843-50.
24. Alison MR. Hepatocyte from non-hepatic adult stem cells. Nature. 2000;406:257-60.
25. Petersen BE. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168-70.
26. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock Gl, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-8.
27. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycaemia in streptozotocin-induced diabetic mice. Diabetes. 2000;49:157-62.
28. Soria B, Skoudy A, Martín F. From stem cells to beta cells: new strategies in cell therpy of diabetes mellitus. Diabetologia. 2001;44:407-15.
29. Taneera J, Rosengren A, Renstrom E, Nygren JM, Serup P, Rorsman P, et al. Failure of transplanted bone marrow cells to adopt a pancreatic β-cell fate. Diabetes. 2006;55:290-6.